Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167387460> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2167387460 endingPage "150" @default.
- W2167387460 startingPage "145" @default.
- W2167387460 abstract "To determine the clinical and economic impact of etanercept 25 mg/week (ETN25) on rheumatoid arthritis (RA), psoriatic arthropathy (PA) and ankylosing spondylitis (AS) patients in sustained clinical remission.Observational, retrospective cohort of patients treated with etanercept 50 mg/week (ETN50) who achieved and maintained clinical remission (Disease Activity Score 28 < 2.6 or BASDAI < 2) over a period of 1 year and had slow worsening of structural changes were enrolled in an off-label program (January 2006 to June 2013) to switch from ETN50 to ETN25. Economic impact was assessed using Enbrel® official prices for Spain.From 1 January 2006 to 1 June 2013, 98 RA, 40 PA and 47 AS patients were treated with ETN50; 39 (24%) patients (20 women; age = 53 ± 7 years; 24 RA, 7 PA, 8 AS) received ETN25 for at least 0.5 years (2.6 ± 2.0 years; range = 0.5 - 7.3 years). As of 1 June 2013, 29 (74%) patients continued on ETN25. RA patients: 17 patients continued on ETN25, 5 patients discontinued use due to reactivation of RA (4 switched back to ETN50 and 1 switched to adalimumab; all regained clinical remission) and 2 patients discontinued use due to adverse reactions. PA patients: four patients continued on ETN25, two patients discontinued use due to reactivation of PA (switched back to ETN50, regaining clinical remission) and one patient discontinued use due to adverse reaction. All AS patients continued on ETN25. The total savings associated with ETN25 over the 7-year observation period were €622,073, resulting in the ability to treat 52 additional patients with ETN50 for one year without increasing total ETN costs.ETN25 produces cost savings while maintaining clinical response in a high proportion of patients after at least one year under clinical remission with ETN50. At a time when the cost of therapy is an unavoidable component of healthcare treatment decisions, ETN25 could be a cost-effective option for selective RA, PA and AS patients." @default.
- W2167387460 created "2016-06-24" @default.
- W2167387460 creator A5022946558 @default.
- W2167387460 creator A5030735944 @default.
- W2167387460 creator A5037188369 @default.
- W2167387460 creator A5043463156 @default.
- W2167387460 creator A5073099255 @default.
- W2167387460 date "2013-12-21" @default.
- W2167387460 modified "2023-10-18" @default.
- W2167387460 title "Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients" @default.
- W2167387460 cites W1964987118 @default.
- W2167387460 cites W1966756689 @default.
- W2167387460 cites W1988152642 @default.
- W2167387460 cites W2009735641 @default.
- W2167387460 cites W2049821801 @default.
- W2167387460 cites W2096703320 @default.
- W2167387460 cites W2114909821 @default.
- W2167387460 cites W2124551692 @default.
- W2167387460 cites W2130894316 @default.
- W2167387460 cites W2133038175 @default.
- W2167387460 cites W2147431442 @default.
- W2167387460 cites W2152348310 @default.
- W2167387460 cites W2155756130 @default.
- W2167387460 cites W2171122996 @default.
- W2167387460 doi "https://doi.org/10.1517/14712598.2014.868433" @default.
- W2167387460 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24359492" @default.
- W2167387460 hasPublicationYear "2013" @default.
- W2167387460 type Work @default.
- W2167387460 sameAs 2167387460 @default.
- W2167387460 citedByCount "16" @default.
- W2167387460 countsByYear W21673874602014 @default.
- W2167387460 countsByYear W21673874602015 @default.
- W2167387460 countsByYear W21673874602016 @default.
- W2167387460 countsByYear W21673874602017 @default.
- W2167387460 countsByYear W21673874602018 @default.
- W2167387460 countsByYear W21673874602019 @default.
- W2167387460 crossrefType "journal-article" @default.
- W2167387460 hasAuthorship W2167387460A5022946558 @default.
- W2167387460 hasAuthorship W2167387460A5030735944 @default.
- W2167387460 hasAuthorship W2167387460A5037188369 @default.
- W2167387460 hasAuthorship W2167387460A5043463156 @default.
- W2167387460 hasAuthorship W2167387460A5073099255 @default.
- W2167387460 hasConcept C126322002 @default.
- W2167387460 hasConcept C141071460 @default.
- W2167387460 hasConcept C197934379 @default.
- W2167387460 hasConcept C2776260265 @default.
- W2167387460 hasConcept C2777226972 @default.
- W2167387460 hasConcept C2777402515 @default.
- W2167387460 hasConcept C2777453003 @default.
- W2167387460 hasConcept C2777575956 @default.
- W2167387460 hasConcept C2779650986 @default.
- W2167387460 hasConcept C2780132546 @default.
- W2167387460 hasConcept C71924100 @default.
- W2167387460 hasConcept C72563966 @default.
- W2167387460 hasConceptScore W2167387460C126322002 @default.
- W2167387460 hasConceptScore W2167387460C141071460 @default.
- W2167387460 hasConceptScore W2167387460C197934379 @default.
- W2167387460 hasConceptScore W2167387460C2776260265 @default.
- W2167387460 hasConceptScore W2167387460C2777226972 @default.
- W2167387460 hasConceptScore W2167387460C2777402515 @default.
- W2167387460 hasConceptScore W2167387460C2777453003 @default.
- W2167387460 hasConceptScore W2167387460C2777575956 @default.
- W2167387460 hasConceptScore W2167387460C2779650986 @default.
- W2167387460 hasConceptScore W2167387460C2780132546 @default.
- W2167387460 hasConceptScore W2167387460C71924100 @default.
- W2167387460 hasConceptScore W2167387460C72563966 @default.
- W2167387460 hasIssue "2" @default.
- W2167387460 hasLocation W21673874601 @default.
- W2167387460 hasLocation W21673874602 @default.
- W2167387460 hasOpenAccess W2167387460 @default.
- W2167387460 hasPrimaryLocation W21673874601 @default.
- W2167387460 hasRelatedWork W2059101060 @default.
- W2167387460 hasRelatedWork W2075066605 @default.
- W2167387460 hasRelatedWork W2075153701 @default.
- W2167387460 hasRelatedWork W2116752853 @default.
- W2167387460 hasRelatedWork W2162495586 @default.
- W2167387460 hasRelatedWork W2236197927 @default.
- W2167387460 hasRelatedWork W2318799791 @default.
- W2167387460 hasRelatedWork W2809810071 @default.
- W2167387460 hasRelatedWork W2980843199 @default.
- W2167387460 hasRelatedWork W4235629817 @default.
- W2167387460 hasVolume "14" @default.
- W2167387460 isParatext "false" @default.
- W2167387460 isRetracted "false" @default.
- W2167387460 magId "2167387460" @default.
- W2167387460 workType "article" @default.